Thu, March 30, 2023
Wed, March 29, 2023
Tue, March 28, 2023
Mon, March 27, 2023
Fri, March 24, 2023
Thu, March 23, 2023

Thomas Shrader Maintained (BCAB) at Strong Buy with Decreased Target to $13 on, Mar 28th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-13-on-mar-28th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Thomas Shrader of BTIG, Maintained "BioAtla, Inc." (BCAB) at Strong Buy with Decreased Target from $68 to $13 on, Mar 28th, 2023.

Thomas has made no other calls on BCAB in the last 4 months.



There are 4 other peers that have a rating on BCAB. Out of the 4 peers that are also analyzing BCAB, 1 agrees with Thomas's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tiago Fauth of "Credit Suisse" Reiterated at Hold and Held Target at $8 on, Friday, March 24th, 2023


These are the ratings of the 3 analyists that currently disagree with Thomas


  • Reni Benjamin of "JMP Securities" Maintained at Buy with Decreased Target to $12 on, Monday, March 27th, 2023
  • Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $25 on, Friday, March 24th, 2023
  • Arthur He of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $17 on, Friday, March 24th, 2023

Publication Contributing Sources